J, F., I, M., R, P., S, S., S, R., & R, S. (2020). Hyperprogression on immunotherapy with complete response to chemotherapy in a NSCLC patient with high PD-L1 and STK11: A case report. Medicine, 99(46), e22323. https://doi.org/10.1097/MD.0000000000022323
Chicago Style (17th ed.) CitationJ, Fricke, Mambetsariev I, Pharaon R, Subbiah S, Rajurkar S, and Salgia R. "Hyperprogression on Immunotherapy with Complete Response to Chemotherapy in a NSCLC Patient with High PD-L1 and STK11: A Case Report." Medicine 99, no. 46 (2020): e22323. https://doi.org/10.1097/MD.0000000000022323.
MLA (9th ed.) CitationJ, Fricke, et al. "Hyperprogression on Immunotherapy with Complete Response to Chemotherapy in a NSCLC Patient with High PD-L1 and STK11: A Case Report." Medicine, vol. 99, no. 46, 2020, p. e22323, https://doi.org/10.1097/MD.0000000000022323.